Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Plasma Exchange | 2 | 2018 | 117 | 1.080 |
Why?
|
| Arrhythmias, Cardiac | 4 | 2019 | 473 | 1.050 |
Why?
|
| Heart Defects, Congenital | 7 | 2022 | 1697 | 1.030 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2023 | 67 | 0.870 |
Why?
|
| Atrial Fibrillation | 2 | 2022 | 719 | 0.860 |
Why?
|
| Heart Diseases | 3 | 2018 | 732 | 0.760 |
Why?
|
| Anticoagulants | 4 | 2022 | 787 | 0.750 |
Why?
|
| Cardiomyopathies | 2 | 2018 | 610 | 0.750 |
Why?
|
| Electrocardiography | 4 | 2018 | 1145 | 0.740 |
Why?
|
| Protein-Losing Enteropathies | 1 | 2020 | 19 | 0.740 |
Why?
|
| Cardiac Rehabilitation | 1 | 2020 | 23 | 0.730 |
Why?
|
| Heart Valve Prosthesis | 1 | 2023 | 386 | 0.670 |
Why?
|
| Factor Xa Inhibitors | 2 | 2018 | 70 | 0.660 |
Why?
|
| Death, Sudden, Cardiac | 3 | 2018 | 253 | 0.640 |
Why?
|
| Sinus of Valsalva | 1 | 2018 | 53 | 0.630 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2020 | 218 | 0.600 |
Why?
|
| Hemorrhage | 2 | 2022 | 712 | 0.600 |
Why?
|
| Exercise Therapy | 1 | 2020 | 288 | 0.590 |
Why?
|
| Thromboembolism | 1 | 2018 | 155 | 0.590 |
Why?
|
| Fontan Procedure | 2 | 2020 | 155 | 0.570 |
Why?
|
| Stroke | 2 | 2022 | 1144 | 0.540 |
Why?
|
| Pulmonary Artery | 2 | 2023 | 499 | 0.530 |
Why?
|
| Cardiac Tamponade | 1 | 2015 | 51 | 0.520 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2015 | 127 | 0.490 |
Why?
|
| Pericardial Effusion | 1 | 2015 | 118 | 0.490 |
Why?
|
| Echocardiography, Transesophageal | 3 | 2020 | 303 | 0.490 |
Why?
|
| Tachycardia, Supraventricular | 3 | 2022 | 84 | 0.490 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2018 | 300 | 0.480 |
Why?
|
| Coronary Vessels | 1 | 2018 | 665 | 0.460 |
Why?
|
| Electric Countershock | 1 | 2014 | 71 | 0.460 |
Why?
|
| Pyridones | 1 | 2015 | 348 | 0.440 |
Why?
|
| Pacemaker, Artificial | 1 | 2015 | 213 | 0.430 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2013 | 192 | 0.400 |
Why?
|
| Administration, Oral | 3 | 2022 | 1544 | 0.390 |
Why?
|
| Electrophysiological Phenomena | 1 | 2011 | 75 | 0.390 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2012 | 99 | 0.380 |
Why?
|
| Survivors | 1 | 2016 | 1031 | 0.380 |
Why?
|
| Exercise | 1 | 2018 | 1183 | 0.380 |
Why?
|
| Cardiac Catheterization | 4 | 2023 | 687 | 0.310 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2016 | 1237 | 0.290 |
Why?
|
| Pyrazoles | 1 | 2015 | 1471 | 0.290 |
Why?
|
| Mass Screening | 1 | 2013 | 1509 | 0.250 |
Why?
|
| Mustard Plant | 1 | 2022 | 4 | 0.220 |
Why?
|
| Vacuum Curettage | 1 | 2022 | 5 | 0.220 |
Why?
|
| Tricuspid Valve | 1 | 2023 | 68 | 0.220 |
Why?
|
| Sotalol | 2 | 2022 | 31 | 0.220 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 1 | 2022 | 24 | 0.210 |
Why?
|
| Humans | 28 | 2023 | 261506 | 0.210 |
Why?
|
| Hospitalization | 3 | 2022 | 2083 | 0.200 |
Why?
|
| Tachycardia, Paroxysmal | 1 | 2020 | 9 | 0.190 |
Why?
|
| Warfarin | 1 | 2022 | 152 | 0.190 |
Why?
|
| Anti-Arrhythmia Agents | 3 | 2022 | 226 | 0.190 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 543 | 0.180 |
Why?
|
| Emergency Service, Hospital | 2 | 2018 | 1148 | 0.180 |
Why?
|
| Adenosine | 1 | 2022 | 289 | 0.180 |
Why?
|
| Coronary Aneurysm | 1 | 2019 | 36 | 0.180 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2020 | 125 | 0.170 |
Why?
|
| Exercise Tolerance | 1 | 2019 | 107 | 0.170 |
Why?
|
| Heart Rate | 2 | 2022 | 737 | 0.170 |
Why?
|
| Nasal Sprays | 1 | 2018 | 7 | 0.170 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2019 | 76 | 0.170 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2019 | 305 | 0.170 |
Why?
|
| Exercise Test | 1 | 2019 | 312 | 0.160 |
Why?
|
| Syncope | 1 | 2018 | 64 | 0.160 |
Why?
|
| Calcium Channel Blockers | 1 | 2018 | 135 | 0.160 |
Why?
|
| Rivaroxaban | 1 | 2018 | 59 | 0.160 |
Why?
|
| Hypoxia | 1 | 2020 | 443 | 0.150 |
Why?
|
| Athletic Injuries | 1 | 2018 | 97 | 0.150 |
Why?
|
| Stents | 3 | 2020 | 1096 | 0.150 |
Why?
|
| Dyspnea | 1 | 2020 | 416 | 0.150 |
Why?
|
| Young Adult | 5 | 2022 | 21445 | 0.150 |
Why?
|
| Incidence | 3 | 2019 | 5673 | 0.150 |
Why?
|
| Blood Coagulation | 1 | 2018 | 185 | 0.150 |
Why?
|
| Adult | 12 | 2022 | 77950 | 0.150 |
Why?
|
| Catheter Ablation | 1 | 2022 | 620 | 0.140 |
Why?
|
| Thrombolytic Therapy | 1 | 2018 | 257 | 0.140 |
Why?
|
| Risk Factors | 4 | 2019 | 17523 | 0.140 |
Why?
|
| Male | 12 | 2022 | 123000 | 0.130 |
Why?
|
| Pericardiocentesis | 1 | 2015 | 33 | 0.130 |
Why?
|
| Tachycardia, Ventricular | 1 | 2018 | 239 | 0.130 |
Why?
|
| Treatment Outcome | 8 | 2022 | 32848 | 0.130 |
Why?
|
| Tertiary Care Centers | 1 | 2017 | 403 | 0.130 |
Why?
|
| Retrospective Studies | 8 | 2022 | 37905 | 0.120 |
Why?
|
| Defibrillators, Implantable | 1 | 2017 | 221 | 0.120 |
Why?
|
| Fractional Flow Reserve, Myocardial | 1 | 2014 | 50 | 0.120 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2014 | 44 | 0.120 |
Why?
|
| Predictive Value of Tests | 4 | 2019 | 4892 | 0.120 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2014 | 133 | 0.110 |
Why?
|
| Transposition of Great Vessels | 1 | 2014 | 124 | 0.110 |
Why?
|
| Athletes | 1 | 2013 | 73 | 0.110 |
Why?
|
| Pregnancy | 2 | 2018 | 7573 | 0.110 |
Why?
|
| Hospitals, Pediatric | 1 | 2017 | 773 | 0.110 |
Why?
|
| Transducers, Pressure | 1 | 2012 | 18 | 0.110 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2012 | 18 | 0.110 |
Why?
|
| Female | 13 | 2022 | 141928 | 0.100 |
Why?
|
| Vascular Access Devices | 1 | 2012 | 51 | 0.100 |
Why?
|
| Blood Pressure Determination | 1 | 2012 | 109 | 0.100 |
Why?
|
| Heart Atria | 1 | 2014 | 352 | 0.100 |
Why?
|
| Arterial Pressure | 1 | 2012 | 107 | 0.100 |
Why?
|
| Adolescent | 4 | 2022 | 31252 | 0.100 |
Why?
|
| United States | 4 | 2018 | 15433 | 0.100 |
Why?
|
| Echocardiography | 1 | 2015 | 1182 | 0.090 |
Why?
|
| Vascular Diseases | 1 | 2012 | 246 | 0.090 |
Why?
|
| Decision Support Techniques | 1 | 2014 | 622 | 0.090 |
Why?
|
| Ischemia | 1 | 2012 | 391 | 0.080 |
Why?
|
| Middle Aged | 6 | 2023 | 86204 | 0.080 |
Why?
|
| Hemodynamics | 1 | 2012 | 935 | 0.080 |
Why?
|
| Survival Rate | 2 | 2018 | 12221 | 0.070 |
Why?
|
| Coronary Artery Disease | 1 | 2014 | 1011 | 0.070 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2014 | 1303 | 0.070 |
Why?
|
| Postoperative Complications | 1 | 2020 | 5542 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 4971 | 0.060 |
Why?
|
| Heart-Assist Devices | 1 | 2013 | 1171 | 0.060 |
Why?
|
| Aged | 5 | 2022 | 70117 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2011 | 4744 | 0.050 |
Why?
|
| Time Factors | 3 | 2022 | 12926 | 0.050 |
Why?
|
| Age Factors | 1 | 2011 | 5377 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2012 | 2403 | 0.050 |
Why?
|
| Infant | 3 | 2022 | 13310 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2018 | 4938 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 29902 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 7551 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2012 | 6869 | 0.040 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 14889 | 0.040 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2018 | 66 | 0.040 |
Why?
|
| Prognosis | 2 | 2014 | 21713 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 7702 | 0.040 |
Why?
|
| Administration, Intravenous | 1 | 2018 | 249 | 0.040 |
Why?
|
| Syndrome | 1 | 2020 | 1351 | 0.040 |
Why?
|
| Electrodes, Implanted | 1 | 2017 | 183 | 0.040 |
Why?
|
| Equipment Failure | 1 | 2017 | 191 | 0.040 |
Why?
|
| Length of Stay | 1 | 2022 | 1900 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2022 | 2218 | 0.030 |
Why?
|
| Reimbursement Mechanisms | 1 | 2014 | 78 | 0.030 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2014 | 46 | 0.030 |
Why?
|
| Surgical Wound Infection | 1 | 2017 | 450 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2014 | 430 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2019 | 16273 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2018 | 2588 | 0.030 |
Why?
|
| Mesenteric Ischemia | 1 | 2012 | 12 | 0.030 |
Why?
|
| Ultrasonography, Interventional | 1 | 2014 | 429 | 0.030 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2012 | 71 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2012 | 310 | 0.020 |
Why?
|
| Angioplasty, Balloon | 1 | 2012 | 183 | 0.020 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2014 | 342 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2022 | 9244 | 0.020 |
Why?
|
| Texas | 1 | 2019 | 6311 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2014 | 761 | 0.020 |
Why?
|
| Equipment Design | 1 | 2012 | 1204 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2014 | 2803 | 0.020 |
Why?
|
| Child | 2 | 2019 | 29154 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2017 | 6100 | 0.020 |
Why?
|
| Disease Management | 1 | 2013 | 1052 | 0.020 |
Why?
|
| Radiography | 1 | 2012 | 1904 | 0.020 |
Why?
|
| Patient Selection | 1 | 2014 | 2055 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2022 | 12873 | 0.020 |
Why?
|